Kovác P - Search Results

1

Synthetic fragments of Vibrio cholerae O1 Inaba O-specific polysaccharide bound to a protein carrier are immunogenic in mice but do not induce protective antibodies.

Meeks MD, Saksena R, Ma X, Wade TK, Taylor RK, Kovác P, Wade WF. Meeks MD, et al. Among authors: kovac p. Infect Immun. 2004 Jul;72(7):4090-101. doi: 10.1128/IAI.72.7.4090-4101.2004. Infect Immun. 2004. PMID: 15213154 Free PMC article.

2

Induction of protective immunity by synthetic Vibrio cholerae hexasaccharide derived from V. cholerae O1 Ogawa lipopolysaccharide bound to a protein carrier.

Chernyak A, Kondo S, Wade TK, Meeks MD, Alzari PM, Fournier JM, Taylor RK, Kovác P, Wade WF. Chernyak A, et al. Among authors: kovac p. J Infect Dis. 2002 Apr 1;185(7):950-62. doi: 10.1086/339583. Epub 2002 Mar 19. J Infect Dis. 2002. PMID: 11920320

3

Length of the linker and the interval between immunizations influences the efficacy of Vibrio cholerae O1, Ogawa hexasaccharide neoglycoconjugates.

Saksena R, Ma X, Wade TK, Kovác P, Wade WF. Saksena R, et al. Among authors: kovac p. FEMS Immunol Med Microbiol. 2006 Jun;47(1):116-28. doi: 10.1111/j.1574-695X.2006.00071.x. FEMS Immunol Med Microbiol. 2006. PMID: 16706794 Free article.

4

Immunogenicity of synthetic saccharide fragments of Vibrio cholerae O1 (Ogawa and Inaba) bound to Exotoxin A.

Wade TK, Saksena R, Shiloach J, Kovác P, Wade WF. Wade TK, et al. Among authors: kovac p. FEMS Immunol Med Microbiol. 2006 Nov;48(2):237-51. doi: 10.1111/j.1574-695X.2006.00143.x. Epub 2006 Sep 29. FEMS Immunol Med Microbiol. 2006. PMID: 17010106 Free article.

5

Neoglycoconjugates from synthetic tetra- and hexasaccharides that mimic the terminus of the O-PS of Vibrio cholerae O:1, serotype Inaba.

Ma X, Saksena R, Chernyak A, Kovác P. Ma X, et al. Among authors: kovac p. Org Biomol Chem. 2003 Mar 7;1(5):775-84. doi: 10.1039/b211660j. Org Biomol Chem. 2003. PMID: 12929359

6

One-pot preparation of a series of glycoconjugates with predetermined antigen-carrier ratio from oligosaccharides that mimic the O-PS of Vibrio cholerae O:1, serotype Ogawa.

Saksena R, Ma X, Kovác P. Saksena R, et al. Among authors: kovac p. Carbohydr Res. 2003 Nov 14;338(23):2591-603. doi: 10.1016/s0008-6215(03)00273-8. Carbohydr Res. 2003. PMID: 14670719

7

Effect of saccharide length on the immunogenicity of neoglycoconjugates from synthetic fragments of the O-SP of Vibrio cholerae O1, serotype Ogawa.

Saksena R, Ma X, Wade TK, Kovác P, Wade WF. Saksena R, et al. Among authors: kovac p. Carbohydr Res. 2005 Oct 17;340(14):2256-69. doi: 10.1016/j.carres.2005.07.017. Carbohydr Res. 2005. PMID: 16098493

8

Progress towards development of a cholera subunit vaccine.

Taylor RK, Kirn TJ, Bose N, Stonehouse E, Tripathi SA, Kovác P, Wade WF. Taylor RK, et al. Among authors: kovac p. Chem Biodivers. 2004 Jul;1(7):1036-57. doi: 10.1002/cbdv.200490078. Chem Biodivers. 2004. PMID: 17191897 Review.

9

Revealing the glycation sites in synthetic neoglycoconjugates formed by conjugation of the antigenic monosaccharide hapten of Vibrio cholerae O1, serotype Ogawa with the BSA protein carrier using LC-ESI-QqTOF-MS/MS.

Jahouh F, Saksena R, Kováč P, Banoub J. Jahouh F, et al. Among authors: kovac p. J Mass Spectrom. 2012 Jul;47(7):890-900. doi: 10.1002/jms.2974. J Mass Spectrom. 2012. PMID: 22791257 Free PMC article.

10

The ABCs (Antibody, B cells, and Carbohydrate epitopes) of cholera immunity: considerations for an improved vaccine.

Provenzano D, Kovác P, Wade WF. Provenzano D, et al. Among authors: kovac p. Microbiol Immunol. 2006;50(12):899-927. doi: 10.1111/j.1348-0421.2006.tb03866.x. Microbiol Immunol. 2006. PMID: 17179659 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

229 results

Search Page

Filters